Crossmark

Trastuzumab deruxtecan for the treatment of HER2-positive advanced gastric cancer: a clinical perspective

Published Online: 2021-03-01

Published Print: 2021-05

Authors

Aoki, Masahiko

Iwasa, Satoru

Boku, Narikazu https://orcid.org/0000-0002-1438-707X
License Information

Text and Data Mining valid from 2021-03-01

Version of Record valid from 2021-03-01
More Information

Article History

Received: 2 December 2020

Accepted: 22 January 2021

First Online: 1 March 2021

Free to read: This content has been made available to all.

Document is current